Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Donlar Biosyntrex Corp. (OTC BB:DBSY.OB)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Chart | News | Profile
Recent Events
Aug 31Price hit new 52-week low ($0.17)
Location
6502 South Archer Road
Bedford Park, IL 60501
Phone: (708) 563-9200
Email: crkoskan@donlar.com
Employees (last reported count): 5
Financial Links
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 91%
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Donlar Biosyntrex Corporation, formerly Biomune Systems, Inc., is a diverse biotech and biopolymer company specializing in the development, manufacture, marketing and sales of both synthetic and natural protein technologies. These protein products are used in a global range of industrial, agricultural, nutraceutical and consumer markets. The synthetic proteins are a new family of biopolymers, known as thermal polyaspartates, that are non-hazardous, non-toxic, hypoallergenic, environmentally friendly and biodegradable. The natural proteins are produced from milk by-products (whey) and contain high levels of immunoglobulins (antibodies) useful in pharmaceutical, nutrient supplement and nutraceutical applications. The Company operates through three business segments, BioPolymers (Industrial Products), AgriSciences (Agriculture) and Optim Nutrition (Nutraceuticals). Donlar Biosyntrex was formed through a reverse acquisition between Biomune Systems and Donlar Corporation in January 2001.
More from Market Guide: Expanded Business Description

Financial Summary
Donlar Biosyntrex Corporation conducts business through three business segments: BioPolymers (performance chemicals business), AgriSciencies (agricultural business), and Optim Nutrition (biomune nutritional and nutraceuticals business). For the six months ended 6/30/01, revenues totalled $1.2 million, up from $583 thousand. Net loss applicable to Common rose 59% to $8.7 million. Results reflect growth in the BioPolymer segment sales, offset by higher warrant costs.
More from Market Guide: Significant Developments

Officers
FY2000 Pay

Larry Koskan, 58
Chairman, Pres, CEO
$31K
Robert Pietrangelo, 60
COO
--  
Joseph Prochaska, 55
VP
--  
Joel Lurquin, 35
Controller, Treasurer, Acting Sec.
--  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- OTC BB:DBSY.OBAs of 31-Aug-2001
Price and Volume
52-Week Low
on 31-Aug-2001
$0.17 
Recent Price$0.20 
52-Week High
on 7-Nov-2000
$2.969
Daily Volume (3-month avg)43.7K
Daily Volume (10-day avg)41.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
26-Week Change-85.8%
26-Week Change
relative to S&P500
-84.5%
Share-Related Items
Market Capitalization$9.15M
Shares Outstanding45.8M
Float4.10M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)-$0.51 
Earnings (ttm)-$0.35 
Earnings (mrq)-$0.09 
Sales (ttm)$0.04 
Cash (mrq)0 
Valuation Ratios
Price/BookN/A 
Price/EarningsN/A 
Price/Sales (ttm)4.45 
Income Statements
Sales (ttm)$2.03M
EBITDA (ttm)-$6.62M
Income available to common (ttm)-$15.9M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-100.24%
Return on EquityN/A 
Financial Strength
Current Ratio (mrq)0.25 
Debt/EquityN/A 
Total Cash (mrq)$5,000 
Short Interest
Shares ShortN/A 
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.